Baker Hughes stock edged 1.3% higher to US$55.23 by Friday's close, a modest move for what was a heavy quarter on headlines. Q3 2026 brought US$8.0b in revenue and adjusted earnings per share of US$0.70, numbers that came alongside US$769m in free cash flow even after sizeable Chart acquisition costs.
The short term read is simple: traders saw a solid quarter. The longer view rests on what that cash generation and the Chart integration mean for multi year earnings power and a highly leveraged balance sheet.
Love Baker Hughes' cash generation but are wary of tying yourself to a highly leveraged balance sheet story? Check out our list of solid balance sheet and fundamentals stocks (25 results).
Data center orders jumped to $4.9B year to date. Ask Charlie what Baker Hughes’ data center wins signal for 2027.
Baker Hughes bulls frame the story around orders and backlog turning into steadier earnings, not just a one quarter pop.
"Record IET orders of US$4.9b in the quarter, a 25% rise in IET orders over the last 4 quarters to US$16.6b and an RPO of US$33.1b support multi year revenue visibility and give a foundation for earnings resilience as this backlog converts."
The latest print goes further than that thesis. IET orders landed at US$5.9b with a 1.7x book to bill and record RPO of US$39.4b. Companywide book to bill of 1.3x and US$10.8b of total orders indicate the order book is still building rather than drawing down.
One Narrative has put a figure on that disagreement. → See the Narrative with its higher Fair Value, assumptions and all.
Bearish investors worry Baker Hughes is stretching its operating model just as it leans on tighter execution. The concern focuses on whether Chart can be absorbed cleanly while multiple moving parts hit earnings quality.
"The planned acquisition of Chart and rapid portfolio reshaping, including multiple divestitures and an HMH IPO, add integration and execution risk at a time when Baker Hughes is relying on US$325 million of cost synergies and US$3 billion of gross proceeds to support its balance sheet."
Q3 synergies of US$70m against a US$325m target show progress, not completion. One time Chart costs cut into free cash flow, and companywide net income and EPS both declined year on year, so margin uplift from integration is not yet visible.
Baker Hughes just showed how a strong cash quarter can be overshadowed by balance sheet concerns. The real opportunity could sit in stocks where fundamentals appear stronger than prevailing market conviction.
Those are three of them. See all 29 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com